Neuroscience
CRISPR Applications in Neuroscience Research
physiopathological hallmarks in neurodegenerative diseases (NDs）
Guerra-Vázquez et al., Foods, 2022
The nervous system is one of the most complex biological systems in the human body.
From neural stem cell expansion and differentiation to neuronal migration, synapse formation, and neural circuit assembly, every stage of nervous system development depends on precisely coordinated gene regulatory networks.
At the same time, genetic disruptions contribute to a wide range of neurological conditions, including neurodevelopmental disorders, neurodegenerative diseases, and psychiatric disorders.
Traditional approaches often make it difficult to answer critical biological questions:
Which genes determine neural cell identity and fate?
How do regulatory networks control neuronal development and maturation?
How do genetic variants contribute to neurological disease?
Which genes represent potential therapeutic targets?
The emergence of CRISPR genome editing technology is transforming neuroscience research from correlation-based observation into precise functional investigation.
By enabling targeted genetic manipulation in stem cells, neurons, brain organoids, and in vivo models, CRISPR allows researchers to systematically investigate the molecular mechanisms underlying the nervous system.
Use CRISPR knockout, CRISPRi, and CRISPRa screening approaches to identify key regulators of neural stem cell maintenance, differentiation, migration, and neuronal maturation.
Combine human brain organoid models with CRISPR screening technologies to investigate gene function within physiologically relevant three-dimensional neural systems.
Generate patient-specific and isogenic iPSC-derived neural disease models through targeted gene knockout, knock-in, and correction.
Apply genome-wide CRISPR screening and CRISPRa/i functional approaches to identify disease-associated regulators and potential intervention targets.
Neural development is a highly coordinated process involving:
Neural stem cell maintenance → Neuronal differentiation → Migration → Maturation → Synaptic network formation
Disruption of these processes can lead to developmental abnormalities and neurological disorders.
CRISPR technology enables researchers to precisely perturb candidate genes and systematically determine their roles in neural development.
Brain organoids generated from pluripotent stem cells can reproduce key aspects of human brain development, providing powerful platforms for studying neurological mechanisms and diseases.
By integrating CRISPR screening with brain organoid technologies, researchers can investigate gene function in complex human neural environments.
Reduce species differences by studying gene function directly in human-derived neural tissues.
Screen hundreds or thousands of candidate genes to identify regulators of neural development and disease phenotypes.
to comprehensively understand genetic perturbation effects.
Induced pluripotent stem cells (iPSCs) enable researchers to generate human neural cells from patient-derived samples.
Combined with CRISPR genome editing, iPSC technology enables precise modeling of disease-associated genetic changes and the generation of highly controlled experimental systems.
Through:
researchers can create experimental systems differing only at the target genetic locus, improving disease mechanism studies.
CRISPR technology is not only a powerful tool for disease modeling but also enables systematic discovery of therapeutic targets for neurological disorders.
| Research Area | Key Scientific Question | CRISPR Strategy | EDITGENE Solution |
| Neural Development Research | Which genes regulate neural formation and maturation? | CRISPR KO/i/a screening | Neural functional genomics screening |
| Brain Organoid Research | How do disease genes affect human neural tissues? | CRISPR screening | Brain organoid screening platforms |
| Disease Modeling | How do genetic mutations cause neurological dysfunction? | KI/KO/Gene correction | iPSC-based isogenic models |
| Target Discovery | Which genes represent therapeutic opportunities? | Genome-wide screening | Functional genomics services |
Supported by:
From:
EDITGENE provides integrated genome engineering solutions from project design to validated research models.
Extensive Experience in Neuroscience Cell Models
Support Across iPSC and Diverse Neural Cell Types
Proprietary sgRNA Design Algorithms
Advanced 3D Bioprinting-Assisted Single-Clone Screening
Proven Track Record with 3,000+ CRO Projects
Broad Expertise Across 400+ Cell Types
From understanding neural development mechanisms to performing brain organoid functional screening; from building iPSC neurological disease models to discovering therapeutic targets—
EDITGENE empowers neuroscience researchers with precise CRISPR genome editing solutions to uncover the molecular principles of the nervous system and accelerate the translation of discoveries into therapeutic strategies.
